Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harinder Gill

Showing results (91-100 of 108) with videos related to

Pageof 11
Sort By:
BMC Cancer|February 11, 2023
Acute promyelocytic leukaemia: population-based study of epidemiology and outcome with ATRA and oral-ATO from 1991 to 2021Harinder Gill, Radha Raghupathy, Carmen Y Y Lee, et al.
Annals of Palliative Medicine|October 21, 2022
Supportive care and symptom management in patients with advanced hematological malignancies: a literature reviewKwok Ying Chan, Thomas Sau Yan Chan, Harinder Gill, et al.
Blood Cancer Journal|July 31, 2025
A clinico-genomic prognostic model for primary myelodysplastic neoplasm in AsiaHarinder Gill, Rita Yim, Paul Lee, et al.
Current Hematologic Malignancy Reports|July 11, 2025
Highlights from MPN Asia 2025: Advances in Molecular Pathogenesis and Therapeutic Strategies in Myeloproliferative NeoplasmsPrithviraj Bose, Zhijian Xiao, Hans C Hasselbalch, et al.
Clinical and Experimental Medicine|September 25, 2023
Management of classical Philadelphia chromosome-negative myeloproliferative neoplasms in Asia: consensus of the Asian Myeloid Working GroupHarinder Gill, Garret M K Leung, Melissa G M Ooi, et al.
Blood Advances|February 27, 2026
Phase 2 study of the lysine-specific demethylase 1 (LSD1) inhibitor bomedemstat for essential thrombocythemiaHarinder Gill, Francesca Palandri, David M Ross, et al.
Blood Advances|April 29, 2026
The lysine-specific demethylase 1 (LSD1) inhibitor bomedemstat in myelofibrosis: results from a phase 1/2 studyHarinder Gill, Abdulraheem Yacoub, Aaron T Gerds, et al.
Cancer|May 16, 2019
Oral arsenic trioxide incorporation into frontline treatment with all-trans retinoic acid and chemotherapy in newly diagnosed acute promyelocytic leukemia: A 5-year prospective studyHarinder Gill, Cyrus R Kumana, Rita Yim, et al.
European Journal of Pediatrics|June 8, 2019
RAPIDOMICS: rapid genome-wide sequencing in a neonatal intensive care unit-successes and challengesAlison M Elliott, Christèle du Souich, Anna Lehman, et al.
Blood Advances|December 18, 2024
Acute Promyelocytic Leukemia Asian Consortium study of arsenic trioxide in newly diagnosed patients: impact and outcomeHarinder Gill, Radha Raghupathy, Hsin-An Hou, et al.
Pageof 11

Showing results (91-100 of 108) with videos related to

Sort By:
Pageof 11
BMC Cancer|February 11, 2023
Acute promyelocytic leukaemia: population-based study of epidemiology and outcome with ATRA and oral-ATO from 1991 to 2021Harinder Gill, Radha Raghupathy, Carmen Y Y Lee, et al.
Annals of Palliative Medicine|October 21, 2022
Supportive care and symptom management in patients with advanced hematological malignancies: a literature reviewKwok Ying Chan, Thomas Sau Yan Chan, Harinder Gill, et al.
Blood Cancer Journal|July 31, 2025
A clinico-genomic prognostic model for primary myelodysplastic neoplasm in AsiaHarinder Gill, Rita Yim, Paul Lee, et al.
Current Hematologic Malignancy Reports|July 11, 2025
Highlights from MPN Asia 2025: Advances in Molecular Pathogenesis and Therapeutic Strategies in Myeloproliferative NeoplasmsPrithviraj Bose, Zhijian Xiao, Hans C Hasselbalch, et al.
Clinical and Experimental Medicine|September 25, 2023
Management of classical Philadelphia chromosome-negative myeloproliferative neoplasms in Asia: consensus of the Asian Myeloid Working GroupHarinder Gill, Garret M K Leung, Melissa G M Ooi, et al.
Blood Advances|February 27, 2026
Phase 2 study of the lysine-specific demethylase 1 (LSD1) inhibitor bomedemstat for essential thrombocythemiaHarinder Gill, Francesca Palandri, David M Ross, et al.
Blood Advances|April 29, 2026
The lysine-specific demethylase 1 (LSD1) inhibitor bomedemstat in myelofibrosis: results from a phase 1/2 studyHarinder Gill, Abdulraheem Yacoub, Aaron T Gerds, et al.
Cancer|May 16, 2019
Oral arsenic trioxide incorporation into frontline treatment with all-trans retinoic acid and chemotherapy in newly diagnosed acute promyelocytic leukemia: A 5-year prospective studyHarinder Gill, Cyrus R Kumana, Rita Yim, et al.
European Journal of Pediatrics|June 8, 2019
RAPIDOMICS: rapid genome-wide sequencing in a neonatal intensive care unit-successes and challengesAlison M Elliott, Christèle du Souich, Anna Lehman, et al.
Blood Advances|December 18, 2024
Acute Promyelocytic Leukemia Asian Consortium study of arsenic trioxide in newly diagnosed patients: impact and outcomeHarinder Gill, Radha Raghupathy, Hsin-An Hou, et al.
Pageof 11